Orchard Therapeutics plc
(NASDAQ CM: ORTX)
Rigrodsky Law, P.A. is investigating Orchard Therapeutics plc (“Orchard”) regarding possible breaches of fiduciary duties and other violations of law related to Orchard’s agreement to be acquired by Kyowa Kirin Co., Ltd. Under the terms of the agreement, Orchard shareholders will receive $16.00 per share in cash.